Scotiabank raised the firm’s price target on American Healthcare REIT (AHR) to $47 from $42 and keeps an Outperform rating on the shares. The firm is updating its price targets on stocks in the U.S. Real Estate & REITs sector under its coverage following Q2 results, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $46 from $44 at Truist
- American Healthcare REIT price target raised to $44 from $38 at Truist
- American Healthcare REIT price target raised to $45 from $39 at RBC Capital
- American Healthcare REIT Reports Strong Earnings Call
- American Healthcare REIT price target raised to $45 from $40 at Citizens JMP